300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Poland
Romania
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
DNA Capital, VC Fund

DNA Capital

VC Fund

São Paulo, Brazil

DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector, ranging from early stage companies to private equity. Our mission is to invest in and provide strategic value to the best companies and founding teams in healthcare. Our team is multidisciplinary, deeply rooted in healthcare and passionate about finding and helping the best companies to thrive. DNA Capital was founded in 2013 and is part of one of the world's leading healthcare groups. We invest globally from our offices located in São Paulo, Brazil and San Francisco, California.

Total investments:
43
Last investment:
Lead investor:
44%
Fund size:
$3.7M
Last fund:

Last updated:

Industries DNA Capital invests in

Health CareMedicalSoftwareHealth InsuranceHospital

Stages DNA Capital invests in

SeedSeries ASeries BSeries CVenture - Series Unknown

Countries DNA Capital invests in

United StatesBrazilChinaSenegalHong Kong

Round sizes

Seed $250k–$8MSeries A $2M–$30MSeries B $4.6M–$30M

Contacts

NameEmailPhoneSocials
See all 7 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$250k–$8M
Series A
$2M–$30M
Series B
$4.6M–$30M

Investment Focus

Industry

  • Health Care 23 (53%)
  • Medical 13 (30%)
  • Software 5 (12%)
  • Health Insurance 5 (12%)
  • Hospital 4 (9%)
See all 47 industries →

Stage

  • Seed 8 (19%)
  • Series A 7 (16%)
  • Series B 5 (12%)
  • Series C 5 (12%)
  • Venture - Series Unknown 3 (7%)
See all 12 stages →

Country

  • United States 13 (30%)
  • Brazil 11 (26%)
  • China 1 (2%)
  • Senegal 1 (2%)
  • Hong Kong 1 (2%)
See all 6 countries →

Team

NameTitleInvestmentsLinksEmail
Partner Total investments: 0
Find email
José Guinle
José Guinle Partner
Partner Total investments: 1
Find email
Luiz Felipe D Martins Costa
Luiz Felipe D Martins Costa Managing Partner
Managing Partner Total investments: 0
Find email
Luiz Noronha
Luiz Noronha Partner
Partner Total investments: 11
Find email
Mario Ribeiro
Mario Ribeiro Partner
Partner Total investments: 0
Find email
See all 7 team members →

Investments

CompanyDescriptionRoundLinks
The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. $15.9M / May 21, 2026
Reema Health is a technology startup transforming how people navigate the gaps between health care and social care. They believe that a personalized, community-based approach to care makes it easy for anyone to access the things they need to make their lives better. $7.5M / Series A / Oct 10, 2024
Hi there, we are Piwi®. Like a broker, only easier. We didn’t create the company because we were in love with the market. It was exactly the opposite. With an easy to use and intuitive digital benefit managing platform we replaced the old school brokerage changing the way in which companies research, buy and manage their health plans and benefits.That’s evolution coming around! $4M / Seed / Oct 01, 2022
Sanar seeks to reshape future doctors and healthcare professionals to be much more efficient and assertive. We started the company as a knowledge platform; from the first moment they step into college, we follow the evolution of the professional throughout their career. Today, Sanar has become a platform for doctors entire lives, offering solutionsfor different stages of their journey: 1 - For students we offer SanarFlix; the platform has a multitude of content from the best teachers in the country and is helping the students to overcome the challenges they face in college. 2 - For the period of admission to medical residency, Sanar offers Sanar Medical Residency, a platform for test preparation to help doctors to enter the best programs in Brazil. 3 - For the general physician, we offer SanarYellow, a clinical decision-making tool with the most up-to-date guidelines, protocols, and drug interactions for point-of-care. 4 - Sanar is also helping to unlock the doctor's potential with SanarUp, a credit product which offers additional income for the most difficult phases of their professional career. Debt Financing / May 25, 2022
Inspirali is an educational institute providing post-graduate training in the health sector. Inspirali provides comprehensive essential knowledge to help individuals develop and qualify their skills so they can become doctors of the future. Inspirali collaborates with partners who share the same vision, and together they move from productdevelopment to technological innovation, always with the goal of empowering future doctors who will democratize access to health. $180.9M / Private Equity / Apr 01, 2022
Reema Health is a technology startup transforming how people navigate the gaps between health care and social care. They believe that a personalized, community-based approach to care makes it easy for anyone to access the things they need to make their lives better. $8M / Seed / Mar 30, 2022
Nice Healthcare is revolutionizing comprehensive healthcare for small and medium-sized businesses with technology and in-home care. Their services include in-home and virtual primary care, virtual mental health therapy, and virtual physical therapy. $30M / Series A / Mar 10, 2022
Cíngulo offers emotional well-being through self-knowledge to improve self-esteem, mood, and attitude. Seed / Mar 09, 2022
Anima Educacao also was known as GAEC Educacao SA, is an educational organization group that focuses on secondary education and universities. It also principally engaged in the educational sector.The Company's activities are divided into two segments: Higher education and Vertical management. It was founded on May 6, 2003, and is based inSao Paulo, Brazil. $178.5M / Post-IPO Equity / Nov 29, 2021
Inspirali is an educational institute providing post-graduate training in the health sector. Inspirali provides comprehensive essential knowledge to help individuals develop and qualify their skills so they can become doctors of the future. Inspirali collaborates with partners who share the same vision, and together they move from productdevelopment to technological innovation, always with the goal of empowering future doctors who will democratize access to health. $178.5M / Secondary Market / Nov 29, 2021
See all 43 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Poland
Romania
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does DNA Capital invest in?

DNA Capital invests primarily in Health Care, Medical and Software startups, most often at Seed and Series A stage. Most of the 43 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does DNA Capital invest in?

DNA Capital typically joins rounds of $250k–$8M at Seed, $2M–$30M at Series A and $4.6M–$30M at Series B. These are whole funding-round sizes, not DNA Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds DNA Capital took part in.

How do I contact DNA Capital?

Public channels for DNA Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at DNA Capital?

The team at DNA Capital includes Carlos de Barros Jorge Neto (Partner), José Guinle (Partner) and Luiz Felipe D Martins Costa (Managing Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
DNA Capital DNA Capital Find emails